Latest Regulatory Risks News

Donaco International reported a modest revenue and EBITDA decline in Q3 FY2025 but strengthened its cash reserves. Meanwhile, the company agreed to a full acquisition scheme at a significant premium, setting the stage for shareholder decisions amid regulatory uncertainties.

St Barbara’s Simberi Gold has formally objected to Papua New Guinea’s tax authority over a disputed PGK456 million assessment, highlighting significant errors and seeking urgent resolution.

Infini Resources Limited has announced a $3.4 million capital raise through a flow-through share offer aimed at advancing exploration at its Portland Creek Uranium Project in Canada. The prospectus highlights significant risks but underscores the company's strategic focus on critical minerals.

BMG Resources has addressed ASX's query on recent share price and volume spikes, confirming no undisclosed information but highlighting imminent assay results from its Abercromby Gold Project.

Argenica Therapeutics reported a 16% reduction in half-year losses to $1.19 million, buoyed by a 29% increase in other income largely from R&D tax incentives, as it advances its neuroprotective drug development.

Coolabah Metals Limited is undertaking a $3-4 million capital raise to fund the acquisition of Broken Hill Mines Pty Ltd and its subsidiary, aiming to re-list on the ASX and focus on developing the Rasp and Pinnacles Mines.

Eureka Group Holdings has acquired a mixed-use residential park in Gladstone, marking its strategic entry into the all-age rental market with promising yield and expansion potential.

Podium Minerals has become the first Australian platinum group metals developer to join the World Platinum Investment Council, gaining access to vital market intelligence and global industry engagement ahead of production.

Marvel Gold Limited has secured extensions for key tenement transfers in Mali, pushing deadlines to 2026 due to the ongoing closure of the Mali Cadastre. This move preserves its strategic foothold in the region amid regulatory uncertainty.

NuCoal Resources has strongly condemned the NSW Premier’s refusal to compensate for losses tied to the 2014 cancellation of its Doyles Creek exploration licence, signaling a protracted battle ahead.

St Barbara has secured A$100 million to fast-track its Simberi Sulphides project, aiming to bring forward production by up to five months, even as Q2 gold output fell short of expectations due to operational challenges.

Medical Developments International has posted a robust improvement in operating cash flow and revenue for Q2 FY25, driven by higher demand and pricing for its flagship product Penthrox across Australia and Europe.